Noveris Health Sciences is trading at CA$0.07, up 8.33%, alongside broader biotech strength, with the sector up 2.09% and no confirmed company-specific catalyst.
- No October 20 company announcement is listed; the latest release shown is dated September 9, 2026.
- Trading volume and activity details were not provided, leaving liquidity context unclear.